277 related articles for article (PubMed ID: 27529327)
21. Validation of claims-based diagnoses of adult and pediatric neuromyelitis optica spectrum disorder and variations in diagnostic evaluation and treatment initiation.
Gmuca S; Hardy DI; Narula S; Stoll S; Harris J; Zhao Y; Xiao R; Weiss PF; Waldman AT; Gerber JS
Mult Scler Relat Disord; 2020 Jan; 37():101488. PubMed ID: 31706167
[TBL] [Abstract][Full Text] [Related]
22. Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.
Evangelopoulos ME; Andreadou E; Koutsis G; Koutoulidis V; Anagnostouli M; Katsika P; Evangelopoulos DS; Evdokimidis I; Kilidireas C
J Neurol Sci; 2017 Jan; 372():92-96. PubMed ID: 28017256
[TBL] [Abstract][Full Text] [Related]
23. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
[TBL] [Abstract][Full Text] [Related]
24. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
[TBL] [Abstract][Full Text] [Related]
25. Neuromyelitis optica (Devic's syndrome).
Wingerchuk DM; Weinshenker BG
Handb Clin Neurol; 2014; 122():581-99. PubMed ID: 24507536
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders.
Jarius S; Franciotta D; Bergamaschi R; Wildemann B; Wandinger KP
Clin Chem Lab Med; 2010 May; 48(5):659-63. PubMed ID: 20184532
[TBL] [Abstract][Full Text] [Related]
27. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T
J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
Popescu BF; Guo Y; Jentoft ME; Parisi JE; Lennon VA; Pittock SJ; Weinshenker BG; Wingerchuk DM; Giannini C; Metz I; Brück W; Shuster EA; Carter J; Boyd CD; Clardy SL; Cohen BA; Lucchinetti CF
Neurology; 2015 Jan; 84(2):148-58. PubMed ID: 25503621
[TBL] [Abstract][Full Text] [Related]
29. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
Paul F; Jarius S; Aktas O; Bluthner M; Bauer O; Appelhans H; Franciotta D; Bergamaschi R; Littleton E; Palace J; Seelig HP; Hohlfeld R; Vincent A; Zipp F
PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296
[TBL] [Abstract][Full Text] [Related]
30. Neuromyelitis optica spectrum disorders in children and adolescents.
Tenembaum S; Chitnis T; Nakashima I; Collongues N; McKeon A; Levy M; Rostasy K
Neurology; 2016 Aug; 87(9 Suppl 2):S59-66. PubMed ID: 27572863
[TBL] [Abstract][Full Text] [Related]
31. [Neuromyelitis optica].
Jarius S; Wildemann B
Nervenarzt; 2007 Dec; 78(12):1365-77. PubMed ID: 17934711
[TBL] [Abstract][Full Text] [Related]
32. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
[TBL] [Abstract][Full Text] [Related]
33. Imaging of Neuromyelitis Optica Spectrum Disorders.
Hung SC
Semin Ultrasound CT MR; 2020 Jun; 41(3):319-331. PubMed ID: 32448488
[TBL] [Abstract][Full Text] [Related]
34. [Neuromyelitis optica/Devic's syndrome: new perspectives].
Lalive PH; Perrin L; Chofflon M
Rev Med Suisse; 2007 Apr; 3(106):950-5. PubMed ID: 17575971
[TBL] [Abstract][Full Text] [Related]
35. [Clinical concept, etiology and pathology of neuromyelitis optica].
Kurosawa K; Fujihara K
Nihon Rinsho; 2014 Nov; 72(11):1897-902. PubMed ID: 25518368
[TBL] [Abstract][Full Text] [Related]
36. Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review.
Pereira WL; Reiche EM; Kallaur AP; Kaimen-Maciel DR
J Neurol Sci; 2015 Aug; 355(1-2):7-17. PubMed ID: 26050520
[TBL] [Abstract][Full Text] [Related]
37. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
Jarius S; Wildemann B
Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune thyroiditis associated with neuromyelitis optica (NMO).
Sudulagunta SR; Sodalagunta MB; Khorram H; Sepehrar M; Gonivada J; Noroozpour Z; Prasad N
Ger Med Sci; 2015; 13():Doc22. PubMed ID: 26633965
[TBL] [Abstract][Full Text] [Related]
39. Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.
Yan Y; Li Y; Fu Y; Yang L; Su L; Shi K; Li M; Liu Q; Borazanci A; Liu Y; He Y; Bennett JL; Vollmer TL; Shi FD
Sci China Life Sci; 2016 Dec; 59(12):1270-1281. PubMed ID: 26920678
[TBL] [Abstract][Full Text] [Related]
40. A comparison of pediatric and adult neuromyelitis optica spectrum disorders: A review of clinical manifestation, diagnosis, and treatment.
Baghbanian SM; Asgari N; Sahraian MA; Moghadasi AN
J Neurol Sci; 2018 May; 388():222-231. PubMed ID: 29478727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
